275 related articles for article (PubMed ID: 17017502)
1. The discovery of dopamine deficiency in the parkinsonian brain.
Hornykiewicz O
J Neural Transm Suppl; 2006; (70):9-15. PubMed ID: 17017502
[TBL] [Abstract][Full Text] [Related]
2. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
3. The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961.
Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):851-4. PubMed ID: 11763859
[No Abstract] [Full Text] [Related]
4. [Short history of L-Dopa].
García Ruiz PJ; Meseguer E
Neurologia; 2002 Apr; 17(4):214-7. PubMed ID: 11940409
[TBL] [Abstract][Full Text] [Related]
5. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
Lees AJ; Tolosa E; Olanow CW
Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease. A half century of progress.
Jankovic J
Neurology; 2001 Nov; 57(10 Suppl 3):S1-3. PubMed ID: 11771154
[No Abstract] [Full Text] [Related]
7. History of levodopa and dopamine agonists in Parkinson's disease treatment.
Tolosa E; Martí MJ; Valldeoriola F; Molinuevo JL
Neurology; 1998 Jun; 50(6 Suppl 6):S2-10; discussion S44-8. PubMed ID: 9633679
[TBL] [Abstract][Full Text] [Related]
8. How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago.
Hornykiewicz O
Wien Klin Wochenschr; 2001 Nov; 113(22):855-62. PubMed ID: 11762121
[No Abstract] [Full Text] [Related]
9. L-DOPA.
Hornykiewicz O
J Parkinsons Dis; 2017; 7(s1):S3-S10. PubMed ID: 28282813
[No Abstract] [Full Text] [Related]
10. A brief history of levodopa.
Hornykiewicz O
J Neurol; 2010 Nov; 257(Suppl 2):S249-52. PubMed ID: 21080185
[TBL] [Abstract][Full Text] [Related]
11. Levodopa: 50 years of a revolutionary drug for Parkinson disease.
Fahn S; Poewe W
Mov Disord; 2015 Jan; 30(1):1-3. PubMed ID: 25488146
[No Abstract] [Full Text] [Related]
12. The history of dopamine and levodopa in the treatment of Parkinson's disease.
Fahn S
Mov Disord; 2008; 23 Suppl 3():S497-508. PubMed ID: 18781671
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent.
Hornykiewicz O
Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520
[TBL] [Abstract][Full Text] [Related]
14. [L-dopa: a fascinating history].
García de Yébenes J; García Ruiz P
Neurologia; 1998; 13 Suppl 1():36-40. PubMed ID: 9859684
[No Abstract] [Full Text] [Related]
15. Current topics in brain dopamine research: a tribute to Professor Oleh Hornykiewicz.
Pifl C; Sperk G
Wien Klin Wochenschr; 2006 Oct; 118(19-20):563-5. PubMed ID: 17136327
[No Abstract] [Full Text] [Related]
16. The L-DOPA story revisited. Further surprises to be expected?
Foley P
J Neural Transm Suppl; 2000; (60):1-20. PubMed ID: 11205132
[TBL] [Abstract][Full Text] [Related]
17. The first miracle in neurodegenerative disease: the discovery of oral levodopa.
Kordower JH; Goetz CG
Brain Res Bull; 1999; 50(5-6):377-8. PubMed ID: 10643443
[No Abstract] [Full Text] [Related]
18. Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's.
Djamshidian A; Poewe W
Parkinsonism Relat Disord; 2016 Dec; 33 Suppl 1():S9-S12. PubMed ID: 28012951
[TBL] [Abstract][Full Text] [Related]
19. [History of treatment of Parkinson disease].
Götz W
Pharm Unserer Zeit; 2006; 35(3):190-7. PubMed ID: 16724522
[No Abstract] [Full Text] [Related]
20. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
Fahn S
Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]